Increases in S-nitrosylation and inactivation of the neuroprotective ubiquitin E3 ligase, parkin, in the brains of patients with Parkinson’s disease are thought to be pathogenic and suggest a possible mechanism linking parkin to sporadic Parkinson’s disease. Here we demonstrate that physiologic modification of parkin by hydrogen sulfide, termed sulfhydration, enhances its catalytic activity. Sulfhydration sites are identified by mass spectrometry analysis and are investigated by site-directed mutagenesis. Parkin sulfhydration is markedly depleted in the brains of patients with Parkinson’s disease, suggesting that this loss may be pathologic. This implies that hydrogen sulfide donors may be therapeutic. The gasotransmitter hydrogen sulfide signals by sulfide modification of target proteins. Vandiver and colleagues study the sulfhydration of parkin by hydrogen sulfide and find that sulfhydration stimulates its activity, and that this activity is reduced in patients with Parkinson’s disease.
Sulfhydration mediates neuroprotective actions of parkin
M. S. Vandiver,B. Paul,Risheng Xu,Senthilkumar S. Karuppagounder,Feng Rao,A. Snowman,H. Ko,Yun-il Lee,V. Dawson,T. Dawson,Nilkantha Sen,Nilkantha Sen,S. Snyder
Published 2013 in Nature Communications
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
Nature Communications
- Publication date
2013-03-18
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-32 of 32 references · Page 1 of 1